Skip to main content

Table 3 Comparison of the clinical, demographic, laboratory and radiological data of the included autism spectrum disorder (ASD) patients (n = 24) according to the severity by Childhood Autism Rating Scale (CARS)

From: Evaluation of serum interleukin-17 A and interleukin-22 levels in pediatric patients with autism spectrum disorder: a pilot study

 

Childhood Autism Rating Scale (CARS) severity

Test value

p-value

Mild

Moderate

Severe

n = 6

n = 13

n = 5

Age (years)

Median (IQR)

5.25 (5–10)

5 (5–8)

7 (6–8)

1.062≠

0.588

Range

413

3.59

3.514

Gender (n., %)

Female

3 (50.0%)

1 (7.7%)

2 (40.0%)

4.677*

0.096

Male

3 (50.0%)

12 (92.3%)

3 (60.0%)

Presence of convulsions (n., %)

No

6 (100.0%)

11 (84.6%)

4 (80.0%)

1.213*

0.545

Yes

0 (0.0%)

2 (15.4%)

1 (20.0%)

Frequency of convulsions (n., %)

Irregular

0 (0.0%)

2 (100.0%)

0 (0.0%)

3.000*

0.083

Every 3 months

0 (0.0%)

0 (0.0%)

1 (100.0%)

Controlled convulsions

Yes

0 (0.0%)

2 (100.0%)

1 (100.0%)

Family history of allergy (n., %)

No

6 (100.0%)

12 (92.3%)

5 (100.0%)

0.883*

0.643

Yes (Asthma)

0 (0.0%)

1 (7.7%)

0 (0.0%)

Family history of autoimmune diseases (n., %)

No

6 (100.0%)

11 (84.6%)

5 (100.0%)

1.846*

0.397

Yes

0 (0.0%)

2 (15.4%)

0 (0.0%)

Score of intelligence quotient (IQ) test

Mean ± SD

65.83 ± 8.82

62.69 ± 8.47

53.60 ± 8.59

3.011•

0.071

Range

55–80

40–70

41–65

Electroencephalogram (EEG) abnormalities (n., %)

Negative

6 (100.0%)

11 (84.6%)

4 (80.0%)

1.213*

0.545

Positive

0 (0.0%)

2 (15.4%)

1 (20.0%)

Interleukin (IL)-17 (pg/mL)

Median (IQR)

262.5 (250–320)

260 (220–300)

360 (320–380)

2.349≠

0.309

Range

120–520

170–440

160–440

Interleukin (IL)-22 (pg/mL)

Median (IQR)

750 (660–850)

700 (600–900)

1120 (920–1150)

4.448≠

0.108

Range

240–1450

400–1100

700–1400

  1. *: Chi-square test; ≠: Kruskal-Wallis test; •: One Way ANOVA test